Upload Avatar (500 x 500)
Leming Shi
lemingshi@fudan.edu.cn
English, Chinese
Shanghai
Fudan University
Life Sciences
  • 1985 - Bachelor's Degree in Analytical Chemistry: Hunan University
  • 1988 - Master's Degree in Computational Chemistry: University of Science and Technology of China
  • 1991 - Ph.D. in Computational Chemistry: Institute of Process Engineering, Chinese Academy of Sciences
  • Published over 200 papers, including 15 in Nature Biotechnology
  • h-index of 55 with over 13,000 citations
  • Co-authored the book 'Big Data and Precision Medicine' (2017)
  • Co-founded the international MAQC Society and served as its first president (2017-2018)
  • 1991-1993 - Assistant Researcher: Institute of Process Engineering, Chinese Academy of Sciences
  • 1993-1994 - Associate Researcher: Institute of Process Engineering, Chinese Academy of Sciences
  • 1994-1997 - Postdoctoral Researcher: Case Western Reserve University and NIH/NCI
  • 1997-2001 - Various roles: FDA, Wyeth, and BASF in the USA
  • 2001 - Co-founder: Shenzhen Chipscreen Biosciences
  • 2003 - Rejoined FDA: Initiated MAQC/SEQC
  • 2011 - Joined Fudan University: Professor at School of Life Sciences, Human Phenome Institute, and affiliated Cancer Hospital
  • 2017 - China Patent Gold Award (4th contributor)
  • 2019 - Chief Scientist of National Key R&D Program 'Strategic International Scientific and Technological Innovation Cooperation'
Chemical Genomics
Pharmacogenomics
Precision Medicine
Medical Big Data
Bioinformatics
Cheminformatics
  • Towards best practice in cancer mutation detection with whole-genome and whole-exome sequencing, Xiao W, Ren L, Wang C, Shi L, 2021
  • Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing, Fang LT, Zhu B, Zhao Y, Hong H, Shi L, Wang C, Xiao W, 2021
  • Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies, Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, Wang P, Shi L, Huang W, Shao ZM, 2019
  • The international MAQC Society launches to enhance reproducibility of high-throughput technologies, Shi L, Tong W, 2017
  • Telomerase activation by genomic rearrangements in high-risk neuroblastoma, Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Shi L, Westermann F, Thomas RK, Fischer M, 2015
  • A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequence Quality Control consortium, Su Z, Łabaj PP, Li S, Kreil DP, Mason CE, Shi L, 2014
  • The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models, Shi L, Wolfinger RD, 2010
  • Evaluation of external RNA controls for the assessment of microarray performance, Tong W, Shi L, 2006
  • Rat toxicogenomic study reveals analytical consistency across microarray platforms, Guo L, Shi L, 2006
  • The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements, Shi L, Slikker W Jr, 2006
Chemical Genomics Pharmacogenomics Precision Medicine Medical Big Data Bioinformatics Cheminformatics Biomarkers Disease Prevention Diagnosis Treatment

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.